Massachusetts To Regulate Drug Maker Marketing
The newly formedMassachusetts Prescription Reform Coalition on Thursday announced an effort tocurb pharmaceutical industry marketing in an attempt to bring down drug costsand health spending, the Boston Globe reports. The group contends thatrapid drug spending growth is putting Massachusetts'health care law in jeopardy and hindering other initiatives to expand healthinsurance in the state.
The coalition has three objectives:
- Prohibit gifts from drug makers to health care professionals who prescribe drugs;
- Ban data-mining; and
- Create a drug education program to provide unbiased information to physicians.
Thecoalition was created by Health Care for All, and its members include AARP, the Massachusetts Public Interest Research Group, the American Heart Association, the American Stroke Association, Blue Cross and Blue Shield of Massachusetts and Neighborhood Health Plan.
Stephen Mulloney, director of policy and public affairs for the Massachusetts Biotechnology Council, said, "This campaign seems to be lessabout good public policy and more about animosity toward the biopharmaceuticalindustry." He added that the coalition's efforts could hurt some Massachusetts biotechcompanies (Krasner, Boston Globe, 1/17).
Reprintedwith permission from kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, and sign upfor email delivery at kaisernetwork.org/email . The Kaiser Daily Health PolicyReport is published for kaisernetwork.org, a free service of The Henry J.Kaiser Family Foundation.